FDA preps for upcoming ICCR
This article was originally published in The Rose Sheet
Executive Summary
Public meeting will be held June 19 in Rockville, Md. to provide information and receive comments related to International Cooperation on Cosmetics Regulations (ICCR), a voluntary effort between U.S., Japan, the EU and Canada to remove regulatory obstacles to international trade. FDA will go over topics to be discussed at second round of ICCR steering committee and expert working group meetings in Washington, D.C. the week of July 28, according to the agency's recent notice. In fall 2007, Senator John Kerry, D-Mass., lamented the public's exclusion from the first ICCR meeting in a letter to FDA Commissioner Andrew von Eschenbach (1"The Rose Sheet" Oct. 1, 2007, p. 3). An FDA document detailing the outcome of ICCR's first round of talks became available in March; FDA is accepting comments through July 2 (2"The Rose Sheet" March 10, 2008, In Brief)...